These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 11278251)

  • 1. Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation.
    Ebisawa T; Fukuchi M; Murakami G; Chiba T; Tanaka K; Imamura T; Miyazono K
    J Biol Chem; 2001 Apr; 276(16):12477-80. PubMed ID: 11278251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling.
    Hanyu A; Ishidou Y; Ebisawa T; Shimanuki T; Imamura T; Miyazono K
    J Cell Biol; 2001 Dec; 155(6):1017-27. PubMed ID: 11739411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smurf1 regulates the inhibitory activity of Smad7 by targeting Smad7 to the plasma membrane.
    Suzuki C; Murakami G; Fukuchi M; Shimanuki T; Shikauchi Y; Imamura T; Miyazono K
    J Biol Chem; 2002 Oct; 277(42):39919-25. PubMed ID: 12151385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
    Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal region maintenance 1 (CRM1)-dependent nuclear export of Smad ubiquitin regulatory factor 1 (Smurf1) is essential for negative regulation of transforming growth factor-beta signaling by Smad7.
    Tajima Y; Goto K; Yoshida M; Shinomiya K; Sekimoto T; Yoneda Y; Miyazono K; Imamura T
    J Biol Chem; 2003 Mar; 278(12):10716-21. PubMed ID: 12519765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads.
    Murakami G; Watabe T; Takaoka K; Miyazono K; Imamura T
    Mol Biol Cell; 2003 Jul; 14(7):2809-17. PubMed ID: 12857866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases.
    Morén A; Imamura T; Miyazono K; Heldin CH; Moustakas A
    J Biol Chem; 2005 Jun; 280(23):22115-23. PubMed ID: 15817471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1).
    Komuro A; Imamura T; Saitoh M; Yoshida Y; Yamori T; Miyazono K; Miyazawa K
    Oncogene; 2004 Sep; 23(41):6914-23. PubMed ID: 15221015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor.
    Persson U; Souchelnytskyi S; Franzén P; Miyazono K; ten Dijke P; Heldin CH
    J Biol Chem; 1997 Aug; 272(34):21187-94. PubMed ID: 9261125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad7 differentially regulates transforming growth factor beta-mediated signaling pathways.
    Zhu HJ; Iaria J; Sizeland AM
    J Biol Chem; 1999 Nov; 274(45):32258-64. PubMed ID: 10542264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of Smad7 stability by competition between acetylation and ubiquitination.
    Grönroos E; Hellman U; Heldin CH; Ericsson J
    Mol Cell; 2002 Sep; 10(3):483-93. PubMed ID: 12408818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
    Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
    Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-beta/Smad signaling.
    Ferrigno O; Lallemand F; Verrecchia F; L'Hoste S; Camonis J; Atfi A; Mauviel A
    Oncogene; 2002 Jul; 21(32):4879-84. PubMed ID: 12118366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel E3 ubiquitin ligase Tiul1 associates with TGIF to target Smad2 for degradation.
    Seo SR; Lallemand F; Ferrand N; Pessah M; L'Hoste S; Camonis J; Atfi A
    EMBO J; 2004 Oct; 23(19):3780-92. PubMed ID: 15359284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles for the MH2 domain of Smad7 in the specific inhibition of transforming growth factor-beta superfamily signaling.
    Mochizuki T; Miyazaki H; Hara T; Furuya T; Imamura T; Watabe T; Miyazono K
    J Biol Chem; 2004 Jul; 279(30):31568-74. PubMed ID: 15148321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHIP controls the sensitivity of transforming growth factor-beta signaling by modulating the basal level of Smad3 through ubiquitin-mediated degradation.
    Xin H; Xu X; Li L; Ning H; Rong Y; Shang Y; Wang Y; Fu XY; Chang Z
    J Biol Chem; 2005 May; 280(21):20842-50. PubMed ID: 15781469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arkadia amplifies TGF-beta superfamily signalling through degradation of Smad7.
    Koinuma D; Shinozaki M; Komuro A; Goto K; Saitoh M; Hanyu A; Ebina M; Nukiwa T; Miyazawa K; Imamura T; Miyazono K
    EMBO J; 2003 Dec; 22(24):6458-70. PubMed ID: 14657019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of responsiveness to TGF-beta1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptors and Smad proteins, suggests a novel mechanism for TGF-beta insensitivity in carcinoma cells.
    Heldin NE; Bergström D; Hermansson A; Bergenstråhle A; Nakao A; Westermark B; ten Dijke P
    Mol Cell Endocrinol; 1999 Jul; 153(1-2):79-90. PubMed ID: 10459856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of TGF-beta related Smad proteins in human epithelial skin tumors.
    Lange D; Persson U; Wollina U; ten Dijke P; Castelli E; Heldin CH; Funa K
    Int J Oncol; 1999 Jun; 14(6):1049-56. PubMed ID: 10339656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation.
    Zhu H; Kavsak P; Abdollah S; Wrana JL; Thomsen GH
    Nature; 1999 Aug; 400(6745):687-93. PubMed ID: 10458166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.